Invention Application
- Patent Title: ENGINEERING THE HINGE REGION TO DRIVE ANTIBODY DIMERIZATION
-
Application No.: US17615555Application Date: 2020-05-29
-
Publication No.: US20220235148A1Publication Date: 2022-07-28
- Inventor: Fernando GARCES , Zhulun WANG
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- International Application: PCT/US2020/035196 WO 20200529
- Main IPC: C07K16/46
- IPC: C07K16/46 ; C07K16/18

Abstract:
The clinical potential of multispecific antibodies like bispecific and trispecific antibodies shows great promise for targeting complex diseases. However, the generation of those molecules presents great challenges as in many cases it is desired to specifically drive the specific pairing of multiple polypeptide chains that are present in solutions. In the case of the heavy chains, there are two main regions that form a dimer interface. One of them is the CH3 region, which has been widely exploited by inserting either charge-pair mutations (CPMs) to steer the dimer interface or inserting large bulky residues into cavities (Knob in Hole) to physically favor and disfavor the dimer formation. However, each of these strategies may not be applied to every molecule and therefore there is the need for more tools. Here, we describe the engineering of the Hinge region with a small number of mutations that are capable to alone successfully drive the heavy chain dimerization.
Information query